Qingdao Vland Biotech Co Ltd Working Capital to Net Assets Ratio
Qingdao Vland Biotech Co Ltd working capital to net assets ratio. Qingdao Vland Biotech Co Ltd (603739) has a Working Capital to Net Assets ratio of 4.5% as of September 2025. Working capital of CN¥85.94 Million (current assets of CN¥1.15 Billion minus current liabilities of CN¥1.06 Billion) is measured against net assets of CN¥1.90 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Qingdao Vland Biotech Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Qingdao Vland Biotech Co Ltd (2014–2024)
Working capital to net assets ratio of Qingdao Vland Biotech Co Ltd from 2014 to 2024. This chart shows how Qingdao Vland Biotech Co Ltd's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 4.5%, reflecting working capital of CN¥85.94 Million against net assets of CN¥1.90 Billion CNY. See 603739 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Qingdao Vland Biotech Co Ltd Working Capital to Net Assets Ratio by Year (2014–2024)
Qingdao Vland Biotech Co Ltd working capital to net assets ratio by year from 2014 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Qingdao Vland Biotech Co Ltd from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 603739 asset base.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 2.0% | CN¥37.75 Million | CN¥1.87 Billion | CN¥1.07 Billion | CN¥1.03 Billion | ▲ +0.1 pp |
| 2023 | 2.0% | CN¥35.77 Million | CN¥1.83 Billion | CN¥1.12 Billion | CN¥1.09 Billion | ▼ -16.7 pp |
| 2022 | 18.7% | CN¥324.31 Million | CN¥1.73 Billion | CN¥969.40 Million | CN¥645.09 Million | ▼ -16.9 pp |
| 2021 | 35.6% | CN¥599.50 Million | CN¥1.69 Billion | CN¥971.82 Million | CN¥372.33 Million | ▼ -6.5 pp |
| 2020 | 42.1% | CN¥469.43 Million | CN¥1.12 Billion | CN¥742.22 Million | CN¥272.80 Million | ▼ -8.5 pp |
| 2019 | 50.6% | CN¥522.13 Million | CN¥1.03 Billion | CN¥705.91 Million | CN¥183.78 Million | ▲ +17.6 pp |
| 2018 | 32.9% | CN¥207.94 Million | CN¥631.38 Million | CN¥460.49 Million | CN¥252.55 Million | ▼ -3.0 pp |
| 2017 | 35.9% | CN¥212.68 Million | CN¥592.53 Million | CN¥439.22 Million | CN¥226.55 Million | ▼ -0.8 pp |
| 2016 | 36.7% | CN¥204.99 Million | CN¥557.97 Million | CN¥406.57 Million | CN¥201.57 Million | ▲ +4.4 pp |
| 2015 | 32.3% | CN¥167.79 Million | CN¥519.36 Million | CN¥388.54 Million | CN¥220.74 Million | ▼ -3.5 pp |
| 2014 | 35.8% | CN¥167.14 Million | CN¥466.26 Million | CN¥395.02 Million | CN¥227.88 Million | — |